Puma Biotechnology
PBYI
PBYI
119 hedge funds and large institutions have $889M invested in Puma Biotechnology in 2016 Q1 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 33 reducing their positions, and 32 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
less ownership
Funds ownership: →
less funds holding
Funds holding: →
41% less first-time investments, than exits
New positions opened: 19 | Existing positions closed: 32
65% less capital invested
Capital invested by funds: $2.52B → $889M (-$1.63B)
100% less funds holding in top 10
Funds holding in top 10: 2 → 0 (-2)
Holders
119
Holding in Top 10
–
Calls
$13.8M
Puts
$9.56M
Top Buyers
| 1 | +$39.9M | |
| 2 | +$15.1M | |
| 3 | +$8.82M | |
| 4 |
VAM
Visium Asset Management
New York
|
+$6.34M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.23M |
Top Sellers
| 1 | -$33.8M | |
| 2 | -$26.1M | |
| 3 | -$23.1M | |
| 4 |
CCI
Columbus Circle Investors
|
-$21.4M |
| 5 |
CGT
Capital Guardian Trust
Los Angeles,
California
|
-$21.3M |